The Safest Way To Start Trading Is Here!
One look at Wall Street right now and anyone can tell: it’s a mess! But new trades can get an edge with “Options Trading Made Easy” by trading champion Chuck Hughes, the best guide to options trading in the modern market.

Start with a small investment today and see where you can go!

Get your copy now!
Patrick Kaltenbach, insider at Becton, Dickinson and

Patrick Kaltenbach Insider Information

Patrick Kaltenbach joined the company in January 2021 and was appointed President and Chief Executive Officer in April 2021.

Prior to joining the company, he served as the lead of the Life Sciences Segment at Becton Dickinson since 2018. He was President of the Life Sciences and Applied Markets Group at Agilent from 2014 to 2018. Previously, he held wide-ranging roles of increasing leadership responsibility at Agilent and its predecessor company, Hewlett Packard, since joining in 1991.

Mr. Kaltenbach is located at the company's headquarters in Greifensee, Switzerland. He and his wife reside in Zurich.

Patrick Kaltenbach is a German national.

What is Patrick Kaltenbach's net worth?

The estimated net worth of Patrick Kaltenbach is at least $318,778.80 as of February 17th, 2021. Mr. Kaltenbach owns 1,266 shares of Becton, Dickinson and stock worth more than $318,779 as of July 3rd. This net worth estimate does not reflect any other investments that Mr. Kaltenbach may own. Learn More about Patrick Kaltenbach's net worth.

What is Patrick Kaltenbach's salary?

As the EVP of Becton, Dickinson and Company, Mr. Kaltenbach earned a total compensation package of $3,671,198.00 in 2020. Mr. Kaltenbach earned a salary of $636,025.00, a bonus of $750,000.00, stock awards of $1,329,930.00, non-equity compensation of $490,827.00, and other compensation of $70,673.00. Learn More on Patrick Kaltenbach's salary.

How do I contact Patrick Kaltenbach?

The corporate mailing address for Mr. Kaltenbach and other Becton, Dickinson and executives is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. Becton, Dickinson and can also be reached via phone at (201) 847-6800. Learn More on Patrick Kaltenbach's contact information.

Has Patrick Kaltenbach been buying or selling shares of Becton, Dickinson and?

Patrick Kaltenbach has not been actively trading shares of Becton, Dickinson and during the past quarter. 0 shares of the firm's stock in a transaction dated Sunday, July 3rd. Learn More on Patrick Kaltenbach's trading history.

Who are Becton, Dickinson and's active insiders?

Becton, Dickinson and's insider roster includes Simon Campion (EVP), Alexandre Conroy (EVP), Claire Fraser (Director), Roland Goette (EVP), David Hickey (EVP), Patrick Kaltenbach (EVP), Samrat Khichi (EVP), Betty Larson (EVP), James Lim (EVP), Thomas Polen, Jr. (Insider), Rebecca Rimel (Director), and Thomas Spoerel (VP). Learn More on Becton, Dickinson and's active insiders.

Are insiders buying or selling shares of Becton, Dickinson and?

During the last year, insiders at the medical instruments supplier sold shares 15 times. They sold a total of 35,210 shares worth more than $9,346,078.60. The most recent insider tranaction occured on June, 7th when VP Thomas J Spoerel sold 443 shares worth more than $115,180.00. Insiders at Becton, Dickinson and own 0.5 % of the company. Learn More about insider trades at Becton, Dickinson and.

Information on this page was last updated on 6/7/2022.

Patrick Kaltenbach Insider Trading History at Becton, Dickinson and

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/9/2020Sell1,272$260.00$330,720.0010,340View SEC Filing Icon  
6/5/2020Sell1,049$243.20$255,116.8012,661View SEC Filing Icon  
12/12/2019Sell339$263.23$89,234.9719,546View SEC Filing Icon  
6/10/2019Sell191$241.03$46,036.7319,072View SEC Filing Icon  
6/4/2019Sell275$235.00$64,625.0016,482View SEC Filing Icon  
See Full Table

Patrick Kaltenbach Buying and Selling Activity at Becton, Dickinson and

This chart shows Patrick Kaltenbach's buying and selling at Becton, Dickinson and by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Becton, Dickinson and Company Overview

Becton, Dickinson and logo
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Read More

Today's Range

Now: $251.80
Low: $244.32
High: $252.17

50 Day Range

MA: $249.80
Low: $234.74
High: $259.64

2 Week Range

Now: $251.80
Low: $231.46
High: $280.62


774,915 shs

Average Volume

1,101,136 shs

Market Capitalization

$71.78 billion

P/E Ratio


Dividend Yield



Trading Isn’t Getting Easier–But Options Just Did!
Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!